Phillips-Medisize A/S

Phillips-Medisize A/S (CVR number: 24053415K) is a company from STRUER. The company reported a net sales of 481.9 mDKK in 2023, demonstrating a growth of 27.5 % compared to the previous year. The operating profit percentage was at 23.5 % (EBIT: 113.5 mDKK), while net earnings were 83.4 mDKK. The profitability of the company measured by Return on Assets (ROA) was 33.8 %, which can be considered excellent and Return on Equity (ROE) was 41.8 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 71.6 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. Phillips-Medisize A/S's liquidity measured by quick ratio was 3.2 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.